REFERENCES
- Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341:394–402.
- Magder LS, Mofenson L, Paul ME, et al. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr 2005;38:87–95.
- Recommendations for Use of Antiretroviral Drugs in Preg-nant HIV-1-Infected Women for Maternal Health and Inter-ventions to Reduce Perinatal HIV Transmission in the United States - May 24, 2010. http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?Menultem=Guidelines&Search=0ff&GuidelinelD=9&ClassID=2. Accessed September 8, 2010.
- Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007;1 :CD003510.
- Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22:289–299.
- Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973–981.
- Galli L, Puliti D, Chiappini E, et al. Is the interruption of anti-retroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Clin Infect Dis. 2009;48:1310–1317.
- Katz IT, Shapiro R, Li D, et al. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study. J Acquir Immune Defic Syndr January 8, 2010. [Epub ahead of print]
- Girardi E, Vanacore P, Costa F, et al. Trends in HIV preva-lence among pregnant women in Italy, 1994 to 2002. J Acquir Immun Defic Syndr 2006;41:361–364.
- Tubiana R, Le Chenadec J, Rouzioux C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS C01). Clin Infect Dis. 2010;50:585–596.
- European Collaborative Study. Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. Antivir Ther 2010;15:41–49.
- Floridia M, Tamburrini E, Ravizza M, et al. Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contra-indicated drugs. Antivir Ther 2006;11:941–946.
- Tamburrini E, Ravizza M, Floridia M, et al. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy. Antivir Ther 2008;13:519–527.
- Fernandez-lbieta M, Ramos Amador JT, Guillén Martin S, et al. Why are HIV-infected infants still being born in Spain? Ann Pediatr (Barc). 2007;67:109–115.
- Macassa E, Burgard M, Veber F, et al. Characteristics of HIV-infected children recently diagnosed in Paris, France. Eur J Pediatr 2006;165:684–687.
- The National Program on Surveillance on Antiretroviral Treatment in Pregnancy. 17th Periodical Study Report. Submitted to Ethics Committee. June 11, 2010.